A 10-year retrospective review was conducted to ascertain the prevalence of inclusion body myositis (IBM) in Western Australia. Seventeen patients with sporadic IBM aged 45–90 years were identified and the prevalence of IBM was calculated to be 9.3 × 10−6. The prevalence was higher in men (10.9 × 10−6) than in women (7.7 × 10−6). The mean age of onset of IBM was 56.6 years, and the mean delay between onset of symptoms and diagnosis was 4.4 years. The age-adjusted prevalence over the age of 50 years was 35.3 × 10−6. The results suggest a higher prevalence of IBM than has previously been reported
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy occurring in adults aged...
We describe a long-term observational study of a large cohort of patients with sporadic inclusion bo...
Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease ...
The prevalence of sIBM is known to vary in different populations. Published figures vary from 4.9 × ...
The prevalence of sporadic inclusion body myositis (sIBM) is variable in different populations and e...
Inclusion body myositis is the most important myopathy associated with aging and usually presents af...
Background: Sporadic Inclusion Body Myositis (sIBM) is a rare and slowly progressive debilitating mu...
The clinical features of inclusion body myositis (IBM) were of minor importance in the design of con...
Sporadic inclusion-body myositis (s-IBM) usually presents after the age of 40 years and is the most ...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Abstract Background Sporadic inclusion body myositis (sIBM) is the most prevalent acquired muscle di...
Sporadic inclusion-body myositis (IBM) is the most common myopathy in individuals over 55 years of a...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy occurring in adults aged...
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy occurring in adults aged...
We describe a long-term observational study of a large cohort of patients with sporadic inclusion bo...
Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease ...
The prevalence of sIBM is known to vary in different populations. Published figures vary from 4.9 × ...
The prevalence of sporadic inclusion body myositis (sIBM) is variable in different populations and e...
Inclusion body myositis is the most important myopathy associated with aging and usually presents af...
Background: Sporadic Inclusion Body Myositis (sIBM) is a rare and slowly progressive debilitating mu...
The clinical features of inclusion body myositis (IBM) were of minor importance in the design of con...
Sporadic inclusion-body myositis (s-IBM) usually presents after the age of 40 years and is the most ...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Abstract Background Sporadic inclusion body myositis (sIBM) is the most prevalent acquired muscle di...
Sporadic inclusion-body myositis (IBM) is the most common myopathy in individuals over 55 years of a...
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they ar...
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy occurring in adults aged...
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy occurring in adults aged...
We describe a long-term observational study of a large cohort of patients with sporadic inclusion bo...
Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease ...